Menu

Madrigal Pharmaceuticals, Inc. MDGL

Full chart Compare
Set alert

Price alert · MDGL

All alert types
399.63 USD -0.47 (-0.12%)

At closeNov 6, 2026, 7:48 PM EST

403.28 +3.65 +0.91%

After hours · Nov 6, 7:48 PM ET

378.28 Day range 401.61
396.32 52-week range 602.83
YTD
-31.38%
1 year
-18.21%

Revenue & Expenses

Other Income → Expenses: $11.81MExpenses → Selling, General & Admin: $813.83MExpenses → Research & Development: $388.52MGross Profit → Expenses: $902.25MRevenue → Gross Profit: $902.25MRevenue → Cost of Revenue: $56.15MNet Loss → Expenses: $288.28MOther Income$11.81MGross Profit$902.25MNet Loss$288.28MCost of Revenue$56.15MExpenses$1.20BSelling, General & Admin$813.83MResearch & Development$388.52MRevenue$958.40M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

MDGL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
958.40M180.13M000
958.40M180.13M000
56.15M6.23M000
902.25M173.90M000
1.20B671.77M380.50M293.57M242.48M
388.52M236.72M272.35M245.44M205.16M
813.83M435.06M108.15M48.13M37.32M
-300.10M-497.88M-380.50M-293.57M-242.48M
22.31M14.67M12.71M3.96M0
-288.28M-465.89M-373.63M-295.35M-241.85M
-288.28M-465.89M-373.63M-295.35M-241.85M
-288.28M-465.89M-373.63M-295.35M-241.85M
-288.28M-465.89M-373.63M-295.35M-241.85M
-12.85-21.90-19.99-17.23-14.63
-12.85-21.90-19.99-17.23-14.63
-12.85-21.90-19.99-17.23-14.63
-265.98M-451.22M-360.92M-291.39M-241.85M
-265.98M-451.22M-360.92M-291.39M-241.85M
22.43M21.27M18.69M17.14M16.54M
22.43M21.27M18.69M17.14M16.54M